Overview: Psychopharmacology in menial retardation and developmental disabilities

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 5, Issue 4, 1999, Pages 251-252

  Schroeder, Stephen R ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PROOPIOMELANOCORTIN; SECRETIN; SEROTONIN AGONIST;

AUTISM; BEHAVIOR THERAPY; CHILD BEHAVIOR; DEVELOPMENTAL DISORDER; EDUCATION; GENETICS; HORMONAL THERAPY; HUMAN; MENTAL DEFICIENCY; NONHUMAN; NUTRITION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW;

EID: 0033377539     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2779(1999)5:4<251::AID-MRDD1>3.0.CO;2-W     Document Type: Review

References (8)

1. Accreditation Council on Services for People with Disabilities (ACD). 1995. Information and orientation packet. Towson, MD: ACD.
2. Health Care Financing Administration. 1992 February 5. Medicare and Medicaid programs; Omnibus nursing home requirements. Proposed rule: Federal Register 57:4516-4534.
3. Kalachnik J, Leventhal BL, et al. 1998. Guidelines for the use of psychotropic medication. In: Reiss S, Aman M, editors. Psychotropic medication and developmental disabilities: The international consensus handbook. Columbus: Ohio State University, p 45-72.
4. Lipman RS. 1970. The use of psychopharmacological agents residential facilities for the retarded. In: Menolascino F, editor. Psychiatric approaches to mental retardation. New York: Basic Books. p 387-398.
5. Rinck C. 1998. Epidemiology and psychoactive medication. In: Reiss S, Aman M, editors. Psychotropic medication and developmental disabilities: the international consensus handbook. Columbus: Ohio State University, p 31-44.
6. Schroeder S, Bouras N, et al. 1998. Past research on psychopharmacology of people with mental retardation and developmental disabilities: the international consensus handbook: Columbus: Ohio State University, p 19-29.
7. Schroeder S. 1985. Issues and future research directs of pharmacotherapy in mental retardation. Psychopharmacol Bull 21:323-326.
8. Sprague R, Werry J. 1971. Methodology in psychopharmacological studies with the retarded. In: Ellis N, editor. International review of research in mental retardation Vol. 5 New York: Academic Press. p 148-220.